Rigel Pharmaceuticals, Inc. · NASDAQ:RIGL
BlackRock, Inc. reported a 7.70% stake in Rigel Pharmaceuticals, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed Apr 17, 2025
BlackRock, Inc. reported a 7.70% stake in Rigel Pharmaceuticals, Inc., 1,381,983 shares, as a passive investor on Mar 31, 2025. Filed Apr 17, 2025 (Schedule 13G/A).
- Stake
- 7.70%
- Shares
- 1,381,983
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 7.70% | 1,381,983 |
Source
Related
- Rigel Pharmaceuticals, Inc.
- BlackRock, Inc.
- Rigel Pharmaceuticals, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Feb 5, 2025
- Form 4 · Schorno Dean L · Sep 3, 2026
- Form 4 · Santos David A · Sep 3, 2026
- Form 4 · Rodriguez Raul R · Sep 3, 2026
- Form 4 · Furey Raymond J. · Sep 3, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026